SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-15-002671
Filing Date
2015-11-13
Accepted
2015-11-13 13:54:59
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cerc-20150930x10q.htm 10-Q 1095116
2 EX-31.1 cerc-20150930ex311bf6ded.htm EX-31.1 16248
3 EX-31.2 cerc-20150930ex312f97d45.htm EX-31.2 16147
4 EX-32.1 cerc-20150930ex321ad48c2.htm EX-32.1 12839
  Complete submission text file 0001558370-15-002671.txt   4855705

Data Files

Seq Description Document Type Size
5 EX-101.INS cerc-20150930.xml EX-101.INS 974523
6 EX-101.SCH cerc-20150930.xsd EX-101.SCH 38904
7 EX-101.CAL cerc-20150930_cal.xml EX-101.CAL 35757
8 EX-101.DEF cerc-20150930_def.xml EX-101.DEF 177134
9 EX-101.LAB cerc-20150930_lab.xml EX-101.LAB 377568
10 EX-101.PRE cerc-20150930_pre.xml EX-101.PRE 275904
Mailing Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202
Business Address 400 E. PRATT ST. SUITE 606 BALTIMORE MD 21202 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 151228371
SIC: 2834 Pharmaceutical Preparations